Carson Wealth (CWM LLC)
FOLD

Carson Wealth (CWM LLC)’s Amicus Therapeutics FOLD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$735K Buy
50,819
+31
+0.1% +$444 ﹤0.01% 1749
2025
Q4 		$723K Buy
50,788
+14,476
+40% +$142K ﹤0.01% 1689
2025
Q3 		$286K Buy
36,312
+26,915
+286% +$192K ﹤0.01% 2170
2025
Q2 		$54K Buy
9,397
+7,502
+396% +$48.4K ﹤0.01% 3222
2025
Q1 		$15K Buy
1,895
+1,531
+421% +$14.2K ﹤0.01% 3870
2024
Q4 		$3K Sell
364
-1,235
-77% -$12.8K ﹤0.01% 4403
2024
Q3 		$17K Buy
1,599
+156
+11% +$1.7K ﹤0.01% 3453
2024
Q2 		$14K Sell
1,443
-309
-18% -$3.17K ﹤0.01% 3337
2024
Q1 		$21K Buy
1,752
+53
+3% +$678 ﹤0.01% 2868
2023
Q4 		$24K Sell
1,699
-49
-3% -$556 ﹤0.01% 2656
2023
Q3 		$21K Buy
1,748
+74
+4% +$955 ﹤0.01% 2651
2023
Q2 		$21K Buy
1,674
+452
+37% +$5.36K ﹤0.01% 2599
2023
Q1 		$14K Buy
1,222
+30
+3% +$370 ﹤0.01% 2735
2022
Q4 		$15K Sell
1,192
-10
-0.8% -$113 ﹤0.01% 2555
2022
Q3 		$13K Hold
1,202
– – ﹤0.01% 2511
2022
Q2 		$13K Sell
1,202
-218
-15% -$1.79K ﹤0.01% 2414
2022
Q1 		$13K Sell
1,420
-45
-3% -$422 ﹤0.01% 2324
2021
Q4 		$17K Buy
+1,465
New +$16.3K ﹤0.01% 2068
2021
Q2 		$1.5M Hold
155,505
– – 0.01% 499
2021
Q1 		$1.5M Hold
155,505
– – 0.01% 499
2020
Q4 		$1.5M Hold
155,505
– – 0.01% 499
2020
Q3 		$1.5M Hold
155,505
– – 0.01% 499
2020
Q2 		$1.5M Hold
155,505
– – 0.01% 499
2020
Q1 		$1.5M Hold
155,505
– – 0.01% 499
2019
Q4 		$1.5M Hold
155,505
– – 0.01% 499
2019
Q3 		$1.5M Hold
155,505
– – 0.01% 499
2019
Q2 		$1.5M Hold
155,505
– – 0.01% 499
2019
Q1 		$1.5M Buy
155,505
+154,540
+16,015% +$1.89M 0.01% 499
2018
Q4 		$9K Buy
+965
New +$10.6K ﹤0.01% 1363

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Carson Wealth (CWM LLC)'s FOLD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Amicus Therapeutics (FOLD) stake by 0.06% in Q1 2026, buying an estimated $444 and bringing the position to 50,819 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

Carson Wealth (CWM LLC) first reported a position in FOLD in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.5M in Q2 2021. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 50,819 shares of Amicus Therapeutics worth $735K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 31 Amicus Therapeutics shares in Q1 2026, an estimated $444.
  • Amicus Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1749 holding.
  • Carson Wealth (CWM LLC) first reported a position in Amicus Therapeutics in Q4 2018 and has held it in 29 quarters since.
  • Carson Wealth (CWM LLC)'s Amicus Therapeutics position peaked at $1.5M in Q2 2021.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.